ABSTRACT
Resumen La enfermedad de Whipple es una enfermedad multisistémica crónica, causada por la bacteria Tropherima whipplei. Se han descripto aproximadamente 1200 casos en la literatura. La incidencia mundial se estima en 9.8 casos por millón de personas. Los datos provenientes de Sudamérica y Europa muestran que afecta a varones de mediana edad. Se cree que los factores inmunológicos del huésped son los que influyen en el curso de la infección y no el genotipo del agente. Dado que las características clínicas no suelen ser específicas y el espectro de manifestaciones en órganos individuales puede ser subestimado, el diagnóstico sigue siendo muy difícil. Presentamos un caso confirmado por histopatología con compromiso multisistémico. Consideramos importante su difusión dados los escasos casos documentados en Sudamérica y la relevancia de tener presente la sospecha diagnóstica para el abordaje terapéutico precoz que mejora el pronóstico de esta rara enfermedad.
Abstract Whipple's disease is a chronic mutisystem disease caused by the bacteria Tropherima whipplei. Approximately 1200 cases have been described in the literature. The worldwide incidence is estimated at 9.8 cases per million people. Data from South America and Europe show that it affects middle-aged males. It is believed that host immunological factors rather than agent genotypic traits influence the course of the infection. Since the clinical characteristics are usually nonspecific and the wide spectrum of manifestations in individual organs may be underestimated, the diagnosis remains challenging. We present a case with multisystem compromise confirmed by histopathology. We consider its publication important given the few cases documented in South America and the relevance of bearing in mind the importance of an early diagnosis for a prompt treatment that improves the prognosis of this rare disease.
Subject(s)
Humans , Male , Middle Aged , Aged , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/etiology , Whipple Disease/complications , Whipple Disease/diagnosis , Whipple Disease/drug therapy , Europe , Tropheryma , Anti-Bacterial Agents/therapeutic useABSTRACT
Whipple's disease is a chronic mutisystem disease caused by the bacteria Tropherima whipplei. Approximately 1200 cases have been described in the literature. The worldwide incidence is estimated at 9.8 cases per million people. Data from South America and Europe show that it affects middle-aged males. It is believed that host immunological factors rather than agent genotypic traits influence the course of the infection. Since the clinical characteristics are usually nonspecific and the wide spectrum of manifestations in individual organs may be underestimated, the diagnosis remains challenging. We present a case with multisystem compromise confirmed by histopathology. We consider its publication important given the few cases documented in South America and the relevance of bearing in mind the importance of an early diagnosis for a prompt treatment that improves the prognosis of this rare disease.
La enfermedad de Whipple es una enfermedad multisistémica crónica, causada por la bacteria Tropherima whipplei. Se han descripto aproximadamente 1200 casos en la literatura. La incidencia mundial se estima en 9.8 casos por millón de personas. Los datos provenientes de Sudamérica y Europa muestran que afecta a varones de mediana edad. Se cree que los factores inmunológicos del huésped son los que influyen en el curso de la infección y no el genotipo del agente. Dado que las características clínicas no suelen ser específicas y el espectro de manifestaciones en órganos individuales puede ser subestimado, el diagnóstico sigue siendo muy difícil. Presentamos un caso confirmado por histopatología con compromiso multisistémico. Consideramos importante su difusión dados los escasos casos documentados en Sudamérica y la relevancia de tener presente la sospecha diagnóstica para el abordaje terapéutico precoz que mejora el pronóstico de esta rara enfermedad.
Subject(s)
Hypertension, Pulmonary , Whipple Disease , Aged , Anti-Bacterial Agents/therapeutic use , Europe , Humans , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/etiology , Male , Middle Aged , Tropheryma , Whipple Disease/complications , Whipple Disease/diagnosis , Whipple Disease/drug therapyABSTRACT
The evidence available in the pediatric population is limited for making clinical decisions regarding the optimization of tacrolimus (TAC) in pharmacotherapy. The objective of this study was to estimate the frequency of CYP3A5 genetic polymorphisms and their relationship with tacrolimus requirements in the pediatric population. This was a longitudinal cohort study with a two-year follow-up of 77 patients under 18 years old who underwent a liver transplant during the period 2009-2012 at the J.P. Garrahan Pediatric Hospital. Tacrolimus levels from day five up to two years after the transplant were obtained from hospital records of routine therapeutic drug monitoring. The genotyping of CYP3A5 (CYP3A5*1/*3 or *3/*3) was performed in liver biopsies from both the donor and the recipient. The frequency of CYP3A5*1 expression for recipients was 37.1% and 32.2% for donors. Patients who received an expresser organ showed lower Co/dose, especially following 90 days after the surgery. The role of each polymorphism is different according to the number of days after the transplant, and it must be taken into account to optimize the benefits of TAC therapy during the post-transplant induction and maintenance phases.
ABSTRACT
Anteriormente la neoplasia quística mucinosa del hígado (NQM-H) se había clasificado como cistoadenoma biliar o cistoadenocarcinoma biliar. Sin embargo, la Organización Mundial de la Salud en la clasificación del 2010 definió la NQM-H como contrapartida de la NQM del páncreas (NQM-P). En ambos casos se requiere la presencia de estroma ovárico para establecer el diagnóstico. La NQM-H es una rara enfermedad que se produce en una frecuencia mucho menor que la pancreática y sus características biológicas han sido poco esclarecidas. Presentamos un caso de NQM-H en una paciente de 33 años que fue tratada con resección quirúrgica.(AU)
Subject(s)
Neoplasms, Cystic, Mucinous, and Serous , LiverABSTRACT
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for early PTLD detection. Transversal study: paired peripheral blood mononuclear cells (PBMC), plasma and oropharyngeal lymphoid tissue (OLT) from children undergoing a solid organ transplant with (n = 58) and without (n = 47) PTLD. Retrospective follow-up: 71 paired PBMC and plasma from recipients with (n = 6) and without (n = 6) PTLD history. EBV load was determined by real-time PCR. The diagnostic ability to detect all PTLD (categories 1-4), advanced PTLD (categories 2-4) or neoplastic PTLD (categories 3 and 4) was estimated by analyzing the test performance at different cut-off values or with a load variation greater than 0.5 log units. The higher diagnostic performance for identifying all, advanced or neoplastic PTLD, was achieved with cut-off values of 1.08; 1.60 and 2.47 log EBV gEq/10(5) PBMC or 2.30; 2.60; 4.47 log gEq/10(5) OLT cells, respectively. EBV DNA detection in plasma showed high specificity but low (all categories) or high (advanced/neoplastic categories) sensitivity for PTLD identification. Diagnostic performance was greater when: (1) a load variation in PBMC or plasma was identified; (2) combining the measure of EBV load in PBMC and plasma. The best diagnostic ability to identify early PTLD stages was achieved by monitoring EBV load in PBMC and plasma simultaneously; an algorithm was proposed.
La carga alta del virus Epstein-Barr se utiliza como un marcador de desórdenes linfoproliferativos postrasplante (post-transplant lymphoproliferative disorders [PTLD]). El objetivo de este estudio fue validar clínicamente un ensayo de cuantificación del virus Epstein-Barr para la detección temprana de PTLD. Se efectuó un estudio transversal en el que se analizaron muestras pareadas de células mononucleares periféricas (CMP), de plasma y de tejido linfoide orofaríngeo de niños con trasplante de órgano sólido, con PTLD (n = 58) y sin PTLD (n = 47). En el seguimiento retrospectivo se incluyeron 71 muestras pareadas de CMP y de plasma de trasplantados, con PTLD (n = 6) y sin PTLD (n = 6). La carga viral se determinó por PCR en tiempo real. Se estimó la capacidad diagnóstica para detectar PTLD (categorías: todas vs. avanzadas vs. neoplásicas) analizando diferentes valores de corte o una variación de carga mayor de 0,5 logaritmos. El mayor desempeño diagnóstico para identificar todos los PTLD, los avanzados y los neoplásicos, se obtuvo con valores de corte de 1,08; 1,60 y 2,47 log copias/10(5) en CMP y de 2,30; 2,60 y 4,48 log copias/10(5) en células de tejido linfoide orofaríngeo, respectivamente. La detección del ADN del virus Epstein-Barr en el plasma mostró una especificidad alta, pero una sensibilidad baja (todas las categorías) o alta (categorías avanzadas o neoplásicas) para identificar PTLD. Se observó el desempeño diagnóstico más alto en las siguientes condiciones: 1) al identificar una variación de carga en CMP o en plasma; 2) combinando la medición de la carga viral en CMP y en plasma. La mejor capacidad diagnóstica para identificar las etapas tempranas de los PTLD se logró mediante el seguimiento simultáneo de la carga viral en CMP y en plasma; se propone un algoritmo.
Subject(s)
Child , Child, Preschool , Humans , Infant , Postoperative Complications/virology , Viremia/diagnosis , Heart Transplantation , Kidney Transplantation , Liver Transplantation , Herpesvirus 4, Human/isolation & purification , Epstein-Barr Virus Infections/virology , Lymphoproliferative Disorders/virology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , DNA, Viral/blood , Leukocytes, Mononuclear/virology , Cross-Sectional Studies , Retrospective Studies , Follow-Up Studies , Immunocompromised Host , Viral Load , Epstein-Barr Virus Infections/diagnosis , Early Detection of Cancer , Real-Time Polymerase Chain Reaction , Lymphoid Tissue/virology , Lymphoma/diagnosis , Lymphoma/etiology , Lymphoma/virology , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/etiologyABSTRACT
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for early PTLD detection. Transversal study: paired peripheral blood mononuclear cells (PBMC), plasma and oropharyngeal lymphoid tissue (OLT) from children undergoing a solid organ transplant with (n=58) and without (n=47) PTLD. Retrospective follow-up: 71 paired PBMC and plasma from recipients with (n=6) and without (n=6) PTLD history. EBV load was determined by real-time PCR. The diagnostic ability to detect all PTLD (categories 1-4), advanced PTLD (categories 2-4) or neoplastic PTLD (categories 3 and 4) was estimated by analyzing the test performance at different cut-off values or with a load variation greater than 0.5log units. The higher diagnostic performance for identifying all, advanced or neoplastic PTLD, was achieved with cut-off values of 1.08; 1.60 and 2.47log EBVgEq/10(5) PBMC or 2.30; 2.60; 4.47loggEq/10(5) OLT cells, respectively. EBV DNA detection in plasma showed high specificity but low (all categories) or high (advanced/neoplastic categories) sensitivity for PTLD identification. Diagnostic performance was greater when: (1) a load variation in PBMC or plasma was identified; (2) combining the measure of EBV load in PBMC and plasma. The best diagnostic ability to identify early PTLD stages was achieved by monitoring EBV load in PBMC and plasma simultaneously; an algorithm was proposed.
Subject(s)
Epstein-Barr Virus Infections/virology , Heart Transplantation , Herpesvirus 4, Human/isolation & purification , Kidney Transplantation , Liver Transplantation , Lymphoproliferative Disorders/virology , Postoperative Complications/virology , Viremia/diagnosis , Child , Child, Preschool , Cross-Sectional Studies , DNA, Viral/blood , Early Detection of Cancer , Epstein-Barr Virus Infections/diagnosis , Follow-Up Studies , Humans , Immunocompromised Host , Infant , Leukocytes, Mononuclear/virology , Lymphoid Tissue/virology , Lymphoma/diagnosis , Lymphoma/etiology , Lymphoma/virology , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/etiology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Real-Time Polymerase Chain Reaction , Retrospective Studies , Viral LoadABSTRACT
Ullrich-Turner syndrome (UTS) is a common chromosomal abnormality caused by partial or complete X chromosome monosomy. One half of the patients have a 45,X karyotype, whereas the remaining patients display other X chromosome anomalies. In 6% to 11% of UTS, a normal or partly deleted Y chromosome has been found. A 10% to 30% risk of developing gonadoblastoma was found in the latter patients. The aim of this study was to evaluate the prevalence of Y chromosome-derived material, the occurrence of gonadoblastoma, and the incidence of possible neoplasms in patients with UTS. Of 217 patients studied with UTS and chromosome analysis of peripheral-blood lymphocytes, Y chromosome material was found in 20 patients. Fluorescence in situ hybridization (FISH) testing was performed to characterize the structurally abnormal Y chromosome in 13 cases. Molecular analysis of the SRY gene could only be performed in 20 patients with 45,X karyotype. Two patients had the SRY genomes. Of the 20 patients with Y chromosome-derived material, 17 underwent gonadectomy. The incidence of gonadoblastoma development in our series was 35.5%. Furthermore, 1 patient also showed a pure dysgerminoma, and another showed a mixed dysgerminoma and embryonal carcinoma. We emphasize the importance of complete processing of the gonadectomy specimen, including step sections, molecular studies, and FISH, in addition to the classic cytogenetic searching for Y chromosome sequences, in patients who present with a nonmosaic 45,X karyotype. Finally, we propose to routinely collect a sample for storage in the tumor bank for future studies.
Subject(s)
Chromosomes, Human, X/genetics , Chromosomes, Human, Y/genetics , Gonadoblastoma/genetics , Ovarian Neoplasms/genetics , Turner Syndrome/genetics , Adolescent , Argentina/epidemiology , Child , Child, Preschool , Female , Genetic Predisposition to Disease , Gonadoblastoma/epidemiology , Gonadoblastoma/pathology , Gonadoblastoma/surgery , Humans , In Situ Hybridization, Fluorescence , Incidence , Karyotype , Karyotyping , Mosaicism , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Phenotype , Sex-Determining Region Y Protein/genetics , Treatment Outcome , Turner Syndrome/epidemiology , Turner Syndrome/pathologyABSTRACT
A coexistence of different renal tumors has rarely been reported. The most commonly described association is of Wilms tumor and renal cell carcinoma. Metanephric adenofibroma has also been associated with Wilms tumor or papillary renal cell carcinoma. Another reported association is metanephric adenoma and papillary renal cell carcinoma with sarcomatoid dedifferentiation. Herein we describe a complex renal tumor containing areas of metanephric adenofibroma, Wilms tumor, and undifferentiated renal cell carcinoma in a previously healthy 18-year-old boy. The tumor showed histologic and immunohistochemical features of these 3 different tumors, offering additional support to the view that these 3 tumors are related.
Subject(s)
Adenofibroma/diagnosis , Carcinoma, Renal Cell/diagnosis , Kidney Neoplasms/diagnosis , Neoplasms, Multiple Primary/diagnosis , Wilms Tumor/diagnosis , Adenofibroma/metabolism , Adenofibroma/therapy , Adolescent , Biomarkers, Tumor/metabolism , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/secondary , Carcinoma, Renal Cell/therapy , Combined Modality Therapy , Fatal Outcome , Humans , Kidney Neoplasms/metabolism , Kidney Neoplasms/therapy , Male , Neoplasm Recurrence, Local , Neoplasms, Multiple Primary/metabolism , Neoplasms, Multiple Primary/secondary , Neoplasms, Multiple Primary/therapy , Nephrectomy , Wilms Tumor/metabolism , Wilms Tumor/secondary , Wilms Tumor/therapyABSTRACT
This study was designed to describe the bone marrow features of multisystem Langerhans cell histiocytosis (LCH) at diagnosis in patients with or without hematologic dysfunction. A retrospective review of bone marrow biopsies from patients with multisystem LCH was performed. Cases were diagnosed at the Garrahan Hospital between 1987 and 2004. Routine and immunohistochemistry techniques (hematoxylin-eosin, periodic acid-Schiff, Giemsa, Gomori reticulin, and CD1a, CD68, and CD61) were evaluated. Clinical outcome and laboratory data were obtained from the medical charts. Twenty-two bone marrow biopsies from patients with multisystem LCH were reviewed at onset of disease. Four patients had no hematologic dysfunction and the other 18 patients had monocytopenia (9), bicytopenia (7), or tricytopenia (2). Increased number and dysplasia of megakaryocytes were evident in 22/22 samples and emperipolesis was present in 21/22 (95%). Aggregates of histiocytes and hemophagocytosis were seen in 9/22 samples. Myelofibrosis was found in 16/17 (94%) evaluable samples at diagnosis. No association of myelofibrosis and cytopenias or clinical outcome was found. Positive CD1a confirmed the presence of LCH cells in 3/22 (14%) samples. Hemophagocytosis and poor outcome were significantly more common in patients with bilineage and trilineage cytopenias. Langerhans cell histiocytosis cells were rarely seen in the bone marrow of these patients (14%); increased histiocytes and hemophagocytosis were more commonly found (41%). Hemophagocytosis was associated with severe cytopenias. Bicytopenia and tricytopenia were associated with poor outcome (death). Myelofibrosis, megakaryocytic dysplasia, and emperipolesis were common findings.
Subject(s)
Bone Marrow/pathology , Histiocytosis, Langerhans-Cell/pathology , Bone Marrow Examination , Child, Preschool , Female , Humans , Infant , Male , Retrospective StudiesSubject(s)
Humans , Cell Cycle/genetics , Colonic Neoplasms , Molecular Biology , Neoplasm Staging , PrognosisSubject(s)
Humans , Colonic Neoplasms , Molecular Biology , Cell Cycle/genetics , Neoplasm Staging , PrognosisABSTRACT
La recidiva locoregional en cáncer de colon y recto es uno de los mayores problemas que enfrenta el cirujano de colon y el encólogo. Una adecuada estadificación es esencial para planificar y establecer el tratamiento post operatorio. P53 es un evento frecuente en el cáncer de colon y recto y se postuló como un posible factor pronóstico independiente. Objetivo: este estudio fue diseñado para evaluar si la sobreexpresión de p53 en pacientes con carcinoma primario de colon y recto con seguimiento clínico mayor de 5 años en estadío A, B ó C de Dukes y correlacionar con edad, sexo, grado de diferenciación histológico y nuclear, estadíos de Dukes y supervivencia. Resultados: sobreexpresión de p53 se detectó en 32 pacientes (71 por ciento). No se encontró diferencia significativa entre la sobreexpresión de p53 y los factores clínico-patológicos analizados. Se encontró correlación estadística entre estadío de Dukes y supervivencia. Conclusión: en nuestro estudio no hemos encontrado que p53 fuera un factor pronóstico independiente en los estadíos A, B y C de Dukes. El estadío de Dukes continúa siendo el factor pronóstico más importante.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/surgery , Genes, p53/genetics , Genes, p53/physiology , Neoplasm Metastasis/diagnosis , Neoplasm Recurrence, Local , Neoplasm Staging/classification , Prognosis , Follow-Up Studies , ImmunohistochemistryABSTRACT
La recidiva locoregional en cáncer de colon y recto es uno de los mayores problemas que enfrenta el cirujano de colon y el encólogo. Una adecuada estadificación es esencial para planificar y establecer el tratamiento post operatorio. P53 es un evento frecuente en el cáncer de colon y recto y se postuló como un posible factor pronóstico independiente. Objetivo: este estudio fue diseñado para evaluar si la sobreexpresión de p53 en pacientes con carcinoma primario de colon y recto con seguimiento clínico mayor de 5 años en estadío A, B ó C de Dukes y correlacionar con edad, sexo, grado de diferenciación histológico y nuclear, estadíos de Dukes y supervivencia. Resultados: sobreexpresión de p53 se detectó en 32 pacientes (71 por ciento). No se encontró diferencia significativa entre la sobreexpresión de p53 y los factores clínico-patológicos analizados. Se encontró correlación estadística entre estadío de Dukes y supervivencia. Conclusión: en nuestro estudio no hemos encontrado que p53 fuera un factor pronóstico independiente en los estadíos A, B y C de Dukes. El estadío de Dukes continúa siendo el factor pronóstico más importante. (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Colorectal Neoplasms/surgery , Colorectal Neoplasms/diagnosis , Neoplasm Staging/classification , Neoplasm Metastasis/diagnosis , Neoplasm Recurrence, Local , Genes, p53/physiology , Genes, p53/genetics , Prognosis , Follow-Up Studies , ImmunohistochemistryABSTRACT
Biliary atresia (BA) is one of the biliary tree anomaly more frecuent. Occurs in about 0,8 to 1/10.000 live births. BA is defined as a progressive biliary tree. The prognosis depends ond the age of the diagnosis and precocity surgery. We present the resuls of a retrospective analysis of 71 RA carried out at the Garrahan Hospital from 1987 to 1993. 47 were female and 24 were male. Age ranged from 45 to 120 days of life. This study involved a consecutive series of 58 patients with histopathologic study of Porta-hepatis (PH) and liver biopsy obteined during the Kasai. The purpose of this study was to determine the value of histological factors as type of PH and hepatocitic giant cell transformation (GCT). 82.8 per cent had favorable type of PH and the CCT was mild in 84,5 per cent. 72,4 per cent had bad outcome and was independent of the type of PH. Neither of them were statiscaly significant with survive and evolution. In our serice neither PH non CGT were predicators of a bad outcome. There were good outcome in 27.5 per cent, died 37,9 per cent and 10.3 per cent undergo liver transplantation. The precocity in a diagnosis and surgical procedure before two months of age are the most important factors in correlation with survival. Others immunomorphologic factors must be estudied in BA that explained the ethiopatogenic process. Orthotopic liver transplantation is the succesful therapy in childrens with BA.
Subject(s)
Female , Humans , Infant , Biliary Atresia/pathology , Liver/pathology , Biliary Atresia/mortality , Biopsy , Prognosis , Retrospective Studies , Sex Factors , Survival RateABSTRACT
Biliary atresia (BA) is one of the biliary tree anomaly more frecuent. Occurs in about 0,8 to 1/10.000 live births. BA is defined as a progressive biliary tree. The prognosis depends ond the age of the diagnosis and precocity surgery. We present the resuls of a retrospective analysis of 71 RA carried out at the Garrahan Hospital from 1987 to 1993. 47 were female and 24 were male. Age ranged from 45 to 120 days of life. This study involved a consecutive series of 58 patients with histopathologic study of Porta-hepatis (PH) and liver biopsy obteined during the Kasai. The purpose of this study was to determine the value of histological factors as type of PH and hepatocitic giant cell transformation (GCT). 82.8 per cent had favorable type of PH and the CCT was mild in 84,5 per cent. 72,4 per cent had bad outcome and was independent of the type of PH. Neither of them were statiscaly significant with survive and evolution. In our serice neither PH non CGT were predicators of a bad outcome. There were good outcome in 27.5 per cent, died 37,9 per cent and 10.3 per cent undergo liver transplantation. The precocity in a diagnosis and surgical procedure before two months of age are the most important factors in correlation with survival. Others immunomorphologic factors must be estudied in BA that explained the ethiopatogenic process. Orthotopic liver transplantation is the succesful therapy in childrens with BA. (AU)
Subject(s)
Female , Humans , Infant , Biliary Atresia/pathology , Liver/pathology , Survival Rate , Biliary Atresia/mortality , Prognosis , Retrospective Studies , Sex Factors , BiopsyABSTRACT
Introducción: Recientes publicaciones describen la asociación de epilepsia, calcificaciones cerebrales y enfermedad celíaca (EPICAEC) siendo la mayoría de origen italiano. Con el objetivo de descubrir esta concordancia entre enfermedades en nuestro medio se estudiaron 12 pacientes con epilepsia y calcificaciones cerebrales para detectar enfermedad celíaca. Material y métodos: Se estudiaron doce pacientes con epilepsia y calcificaciones cerebrales en los que se descartaron etiologías conocidas. A todos se les realizó electroencefalograma (EEG), tomografía axial computada (TAC) y biopsia peroral de intestino delgado. Resultados: Se diagnosticó enfermedad celíaca en los 12 pacientes. La biopsia intestinal mostró atrofia parcial subtotal en 8 niños; en 2, atrofia parcial severa y en 2, atrofia parcial moderada con aumento de linfocitos intraepiteliales en todos ellos. Once pacientes presentaron convulsiones parciales con síntomas relacionados con un origen en el lóbulo occipital. El EEG fue normal a lo largo de toda la evolución en 7 pacientes. La TAC mostró en todos los pacientes calcificaciones cerebrales de aspecto abullonado y serpinginoso en la región occipital bilateral y en 5, imágenes hipodensas en la sustancia blanca periventricular o alrededor de las calcificaciones. En 5 pacientes las convulsiones precedieron a la aparición de las calcificaciones. Se observó una correlación clara entre el comienzo de la dieta y el control de las convulsiones en 4. Conclusiones: Los resultados mostraron igual concordancia de EPICAEC en nuestro medio que lo expresado en la literatura. Todo paciente con epilepsia y calcificaciones cerebrales de causa no explicada debe ser sometido a una biopsia intestinal para descartar enfermedad celíaca, aun en ausencia de síntomas digestivos (AU)
Subject(s)
Humans , Male , Female , Adolescent , Epilepsy/complications , Celiac Disease/complications , Brain Diseases/diagnostic imaging , Calcinosis/diagnosis , Diet/statistics & numerical data , Celiac Disease/diet therapy , Celiac Disease/pathology , Brain Diseases/diet therapy , Brain Diseases/chemically induced , Calcinosis/diagnostic imaging , Electroencephalography/statistics & numerical dataABSTRACT
Introducción: Recientes publicaciones describen la asociación de epilepsia, calcificaciones cerebrales y enfermedad celíaca (EPICAEC) siendo la mayoría de origen italiano. Con el objetivo de descubrir esta concordancia entre enfermedades en nuestro medio se estudiaron 12 pacientes con epilepsia y calcificaciones cerebrales para detectar enfermedad celíaca. Material y métodos: Se estudiaron doce pacientes con epilepsia y calcificaciones cerebrales en los que se descartaron etiologías conocidas. A todos se les realizó electroencefalograma (EEG), tomografía axial computada (TAC) y biopsia peroral de intestino delgado. Resultados: Se diagnosticó enfermedad celíaca en los 12 pacientes. La biopsia intestinal mostró atrofia parcial subtotal en 8 niños; en 2, atrofia parcial severa y en 2, atrofia parcial moderada con aumento de linfocitos intraepiteliales en todos ellos. Once pacientes presentaron convulsiones parciales con síntomas relacionados con un origen en el lóbulo occipital. El EEG fue normal a lo largo de toda la evolución en 7 pacientes. La TAC mostró en todos los pacientes calcificaciones cerebrales de aspecto abullonado y serpinginoso en la región occipital bilateral y en 5, imágenes hipodensas en la sustancia blanca periventricular o alrededor de las calcificaciones. En 5 pacientes las convulsiones precedieron a la aparición de las calcificaciones. Se observó una correlación clara entre el comienzo de la dieta y el control de las convulsiones en 4. Conclusiones: Los resultados mostraron igual concordancia de EPICAEC en nuestro medio que lo expresado en la literatura. Todo paciente con epilepsia y calcificaciones cerebrales de causa no explicada debe ser sometido a una biopsia intestinal para descartar enfermedad celíaca, aun en ausencia de síntomas digestivos
